Nexentis Technologies Inc.

NXTS ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
SCHEDULE 13G Mar 23, 2026
8-K Mar 17, 2026 8-K
DEF 14A Mar 12, 2026 DEF 14A
PRE 14A Mar 2, 2026 PRE 14A
8-K Feb 26, 2026 8-K
8-K Feb 25, 2026 8-K
SCHEDULE 13G/A Feb 24, 2026
SCHEDULE 13G Feb 12, 2026
4 Feb 11, 2026 4
4 Feb 11, 2026 4
4 Feb 11, 2026 4
4 Feb 11, 2026 4
8-K Jan 13, 2026 8-K
8-K Jan 12, 2026 8-K
8-K Dec 16, 2025 8-K
10-Q Nov 13, 2025 10-Q
8-K/A Nov 12, 2025 8-K/A
DEF 14A Nov 3, 2025 DEF 14A
SCHEDULE 13G Oct 28, 2025
3 Oct 28, 2025
SCHEDULE 13G Oct 24, 2025
3 Oct 24, 2025
PRE 14A Oct 24, 2025 PRE 14A
8-K Oct 23, 2025 8-K
8-K Oct 8, 2025 8-K
← Newer Page 2 of 12 · 298 filings Older →